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Case Report: Intramedullary Cervical 
Spinal Cord Hemangioblastoma with an 
Evaluation of von Hippel-Lindau Disease
Steven Falowski MD, Ashwini Sharan MD, James S. Harrop MD, John K. Ratliff MD
Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania 
History of Present Illness
MO is a 49 year old male with a history of multiple sclerosis who presents with a one year history 
of progressive numbness in his shoulders bilateral and upper back. The patient describes occasional 
sharp pains that radiate to his first three fingers on his right hand. He denies weakness, clumsiness, 
difficulty walking, or bladder/bowel dysfunction. He describes no problems with handwriting, or 
fine motor skills.
Hospital Course 
A MRI of the brain was performed early in the course of symptoms demonstrating his known mul-
tiple sclerosis lesions without any changes. With continued worsening symptoms, further workup 
included an MRI of the cervical spine which demonstrated a 1 cm homogenously enhancing intra-
medullary lesion at C2 with an associated cyst and syrinx.
Prior to surgical intervention, the patient was counseled on the risks entailed in the removal of a 
spinal cord tumor. Based on the characteristics on the MRI, a diagnosis of hemangioblastoma was 
favored and therefore the possibility of having von Hippel-Lindau (VHL) disease was discussed 
with the patient. The patient underwent an MRI of the complete neuro-axis including brain and 
spinal cord screening for any other lesions. An ultrasound of the abdomen was performed which 
demonstrated no renal lesions, liver lesions, or adrenal masses. An ophthalmologic examination 
demonstrated none of the stigmatisms associated with VHL.
Prior to surgical excision, an angiogram was performed for the potential to embolize any large vessels. 
However, no tumor blush was appreciated during the angiogram. 
The patient underwent a laminectomy from C1-3 to expose the spinal cord. Intra-operative ultra-
sound was used to isolate the borders of the nodule and define the cystic component. A dural incision 
and midline myelotomy was performed. The tumor was removed en bloc and the cyst decompressed. 
The tumor was noted to be significantly vascular. Intra- operative ultrasound was utilized to confirm 
full resection. During removal of the tumor somatosensory evoked potentials were noted to decrease 
by approximately 50% in all four extremities.
The patient worked with physical therapy and 
was discharged home on post operative day 
number four. His post operative incisional pain 
was controlled with Percocet. The patient was 
also administered Valium and Neurontin to help 
with the neck pain and parasthesias following 
the surgery. The patient’s neurological exam on 
discharge demonstrated mild numbness in the 
right upper extremity and slight weakness in 
right hand grip, with resolution of preoperative 
sensory deficits in the lower extremities. 
Motor exam was 5/5 in all other muscle 
groups. Postoperative MRI demonstrated no 
residual tumor with expected post operative 
changes. Pathology was consistent with 
hemangioblastoma. In follow up the patients 
remaining right upper extremity numbness had 
resolved and the patient was able to return to 
work 8 weeks postoperatively.
Discussion
The decision to proceed with surgery was based 
on the natural history of this tumor. It may 
continue to grow and with further expanding of 
the syrinx or cystic cavity may produce further 
neurological deterioration. It can be anticipated 
that the best time for surgery would be while the 
patient has a strong neurological status and best 
chance for recovery.
Hemangioblastoma is a vascular neoplasm 
of the central nervous system. It is the most 
common primary neoplasm in the adult cer-
ebellum, but is rarely a tumor of the spine1. 
Hemangioblastoma may occur sporadically 
or as a component of von Hippel-Lindau syn-
drome. Radiological findings such as associated 
cyst, an associated syrinx, and/or surrounding 
spinal cord reaction or edema2, 3 are helpful in 
diagnosing hemangioblastoma. Thirty-two per-
cent of patients with spinal hemangioblastoma 
have von Hippel-Lindau syndrome. Symptoms 
of spinal hemangioblastoma are similar to those 
of other spinal canal tumors and include sensory 
change, motor disturbance, and pain. Because 
the presentation of spinal hemangioblastoma is 
similar to that of other spinal canal masses, MRI 
studies can be useful in suggesting a diagnosis2.
VHL is a rare genetic condition. The disease is 
an autosomal dominant disorder carried on the 
third chromosome with near complete penetra-
tion and variable expression4. The gene behaves 
Past Medical History Hypertension, Diverticulits, Multiple Sclerosis, optic neuritis
Past Surgical History Inguinal hernia repair, Colectomy, Re-anastomosis of bowel
Social History Inguinal hernia repair, Colectomy, Re-anastomosis of bowel
Allergies NKDA
Medications Toprol, Beta Interferon
Initial Neurological Exam The patient’s exam was consistent with a decrease to light touch in  
his bilateral lower extremities and right upper extremity. Pinprick 
and proprioception were intact. Motor strength was 5/5 in all muscle  
groups. There were no difficulties with tandem gait. Reflexes were 2+ 
throughout and symmetric. The patient had showed neither 
Babinski’s nor Hoffman’s sign.
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as a typical tumor suppressor gene. The age of 
onset, as well as severity is variable. There are 
various subtypes which characterize the risks of 
developing renal call carcinoma, pheochromocy-
toma, and angiomatosis. Angiomas are the most 
common presenting signs and symptoms of this 
disease syndrome. Of note, only 20% of patients 
with VHL develop pheochromocytomas. 
Features of VHL can include hemangioblasto-
ma’s in the cerebellum and spinal cord, as well 
as angiomatosis in the retina and other organs.1 
Other features include pheochromocytoma, 
renal cell and pancreatic cysts, renal cell carci-
noma, as well as café au lait spots. Neurological 
sequeala and death arise from complications 
associated with central nervous system tumors, 
as well as cardiovascular instability secondary 
to a pheochromocytoma. Decrease in visual 
acuity and blindness may arise as well5.
Work up for suspected VHL can include genetic 
studies, as well as Vanillylmandelic acid levels 
in urine. Imaging studies can include an MRI 
of the brain and spinal cord, ultrasound and/or 
CT of the abdomen, and ophthalmic exam with 
ocular dopplers5. VHL is usually a progressive 
disease and therapy should begin as soon as the 
diagnosis is made. Surgical treatment is usually 
indicated.
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Figure 1
T1 axial MRI post contrast
Figure 2
T1 sagittal MRI post contrastn?
Figure 3
T2 sagittal MRI
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